Personal Fundraiser

I recently accepted the challenge to climb with Fred Hutch’s Climb to Fight Cancer. Please join me as I raise funds for lifesaving research at Fred Hutch.

In 2020 I co-founded a company called Affini-T Therapeutics (affinittx.com) with three exceptional researchers from Fred Hutch: Phil Greenberg, Aude Chapuis, and Tom Schmitt. Affini-T is working closely with our co-founders to develop T cell therapies for patients with tough-to-treat solid tumors like pancreatic, colorectal and lung cancers. We are advancing towards the clinic in 2023 and hope to treat our first patient at the Fred Hutch. 

Cancer is a devastating disease, estimated to strike one in three women and one in two men in their lifetimes. I am climbing to raise vital funds for Fred Hutch’s lifesaving cancer research. You can help by donating to my climb, which will accelerate the quest for cures.

Fred Hutch has made some of the world’s most important medical advances - from developing bone marrow transplantation as a cure for leukemia, to pioneering powerful therapies that harness the immune system to fight cancer, to leading national and international initiatives that enable earlier cancer diagnoses and more effective treatments. This leading-edge research depends on private contributions that fuel novel studies, which have the power to make a profound difference.

Please join me and donate today. Any amount you can give makes a difference to people and families facing deadly diseases. Your gift is 100% tax deductible and will fund extraordinary research, lifesaving discoveries, and cures. Thank you for your support!

Did you know?

• Fred Hutch has been at the leading edge of cancer research for 45 years - starting with bone marrow transplantation, which can cure some cancers and has helped more than 1 million people. It was pioneered by Dr. E. Donnall Thomas at Fred Hutch. Today, Hutch researchers continue that legacy through groundbreaking work to expand immunotherapy.
• Fred Hutch is a leader in infectious disease research, including breakthrough findings on the herpesvirus and on the pathogens and viruses that cause an estimated 1 in 5 cancers. It is also the home of the HIV Vaccine Trials Network.
• Fred Hutch’s work is centered on the people we serve. This includes research to understand cancer’s toll on individuals and communities; improve health equity, especially among black people and people of color; improve prevention; and treat the entire person, not just the disease.
• Fred Hutch researchers and staff are guided by integrity, scientific excellence, and collaboration - a dedication that has earned them the Gold Seal of Transparency on GuideStar, a service that evaluates more than 2 million U.S. nonprofits.

Best Regards, 

Jak Knowles  | Co-founder, President & CEO

Affini-T Therapeutics